NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 213 filers reported holding NEOGENOMICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,388,000 | -91.5% | 25,779 | -94.2% | 0.00% | -92.3% |
| Q3 2020 | $16,262,000 | -13.0% | 440,832 | -26.9% | 0.03% | -23.5% |
| Q2 2020 | $18,692,000 | +161.0% | 603,347 | +132.6% | 0.03% | +70.0% |
| Q1 2020 | $7,161,000 | +206.8% | 259,347 | +143.8% | 0.02% | +300.0% |
| Q2 2019 | $2,334,000 | -37.0% | 106,395 | -63.8% | 0.01% | -50.0% |
| Q4 2018 | $3,706,000 | +24.2% | 293,890 | +51.2% | 0.01% | +42.9% |
| Q3 2018 | $2,984,000 | +227.2% | 194,365 | +179.5% | 0.01% | +250.0% |
| Q2 2018 | $912,000 | -32.2% | 69,543 | -59.3% | 0.00% | -60.0% |
| Q1 2017 | $1,345,000 | – | 170,674 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |